Literature DB >> 31264853

Synthetic Disaccharide Standards Enable Quantitative Analysis of Stored Heparan Sulfate in MPS IIIA Murine Brain Regions.

Qi Qi He1, Paul J Trim2,3,4, Adeline A Lau5,3, Barbara M King5, John J Hopwood6, Kim M Hemsley5,3, Marten F Snel2,3,4, Vito Ferro1.   

Abstract

Heparan sulfate (HS) is a complex polysaccharide from the glycosaminoglycan (GAG) family that accumulates in tissues in several neurological lysosomal storage diseases known as mucopolysaccharidosis (MPS) disorders. The quantitation of HS in biological samples is important for studying MPS disorders but is very challenging because of its high molecular weight and heterogeneity. Recently, acid-catalyzed butanolysis followed by LC-MS/MS analysis has emerged as a promising method for the determination of HS. Butanolysis of HS produces fully desulfated disaccharide cleavage products which are detected by LC-MS/MS. Herein we describe the synthesis of butylated HS disaccharide standards and their use for determining the identity of major product peaks in LC-MS chromatograms from butanolysis of HS as well as the related GAGs heparin and heparosan. Furthermore, synthesis of a d9-labeled disaccharide internal standard enabled the development of a quantitative LC-MS/MS assay for HS. The assay was utilized for the analysis of MPS IIIA mouse brain tissues, revealing significant differences in abundance and in the regional accumulation of the various HS disaccharides in affected mice.

Entities:  

Keywords:  LC-MS/MS; MPS IIIA; butanolysis; disaccharide standards; heparan sulfate; mucopolysaccharidosis

Year:  2019        PMID: 31264853     DOI: 10.1021/acschemneuro.9b00328

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  4 in total

1.  Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse.

Authors:  Tamara L Paget; Emma J Parkinson-Lawrence; Paul J Trim; Chiara Autilio; Madhuriben H Panchal; Grielof Koster; Mercedes Echaide; Marten F Snel; Anthony D Postle; Janna L Morrison; Jésus Pérez-Gil; Sandra Orgeig
Journal:  Cells       Date:  2021-04-08       Impact factor: 6.600

2.  An Engineered sgsh Mutant Zebrafish Recapitulates Molecular and Behavioural Pathobiology of Sanfilippo Syndrome A/MPS IIIA.

Authors:  Alon M Douek; Mitra Amiri Khabooshan; Jason Henry; Sebastian-Alexander Stamatis; Florian Kreuder; Georg Ramm; Minna-Liisa Änkö; Donald Wlodkowic; Jan Kaslin
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

3.  AAVrh10 Vector Corrects Disease Pathology in MPS IIIA Mice and Achieves Widespread Distribution of SGSH in Large Animal Brains.

Authors:  Michaël Hocquemiller; Kim M Hemsley; Meghan L Douglass; Sarah J Tamang; Daniel Neumann; Barbara M King; Helen Beard; Paul J Trim; Leanne K Winner; Adeline A Lau; Marten F Snel; Cathy Gomila; Jérôme Ausseil; Xin Mei; Laura Giersch; Mark Plavsic; Ralph Laufer
Journal:  Mol Ther Methods Clin Dev       Date:  2019-12-10       Impact factor: 6.698

Review 4.  From Cancer to COVID-19: A Perspective on Targeting Heparan Sulfate-Protein Interactions.

Authors:  Mohit Chhabra; Gareth G Doherty; Nicholas W See; Neha S Gandhi; Vito Ferro
Journal:  Chem Rec       Date:  2021-06-19       Impact factor: 6.935

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.